Therapeutic » Surgery
New technologies delivered to your inbox Subscribe
USP7 Inhibitors to Treat Breast Cancer
2016-117 – Mayo Clinic has discovered that the use of USP7 inhibitors sensitize HER2+breast cancer cells to existing HER2+ therapies.
Defining tomorrow’s medicine with Mayo Clinic inventions
New technologies delivered to your inbox Subscribe
2016-117 – Mayo Clinic has discovered that the use of USP7 inhibitors sensitize HER2+breast cancer cells to existing HER2+ therapies.